Last Updated: 09/12/2024
Enabling mRNA immunogen production and testing
Objectives
To provide an end-to-end immunogen production service using Messenger RNA (mRNA) technology for grantees of the Foundation who are evaluating novel vaccine candidates intended for low/middle income country populations.
External reference
Themes
Date
Nov 2023 — Jul 2025
Total Project Funding
$1.61M
Funding Details
Gates Foundation (GF), United States
Grant ID: INV-055647
Country / Project Site(s)
Related Resources
